PennyStockSites.com

Palo Alto Networks, Inc., Rexahn Pharmaceuticals, Inc., Photon Tech Intl Inc. and Alternative Energy Partners, Inc. Featured from Pennystocksites.com on January 22nd, 2014

 
Repost This

Miami, FL -- (SBWIRE) -- 01/22/2014 -- Pennystocksites.com a leading online financial newsletter source, Reports on the following Companies: Palo Alto Networks, Inc. (NYSE:PANW), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Photon Tech Intl Inc. (OTCMKTS:PHTO) and Alternative Energy Partners, Inc. (OTCBB:AEGY).

Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.

Join Us Here: http://pennystocksites.com/

Palo Alto Networks, Inc. (NYSE:PANW), Palo Alto Networks, Inc. offers a network security platform in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company’s platform comprises Next-Generation Firewall that delivers application, user, and content visibility and control. It delivers its platform in the form of a hardware or virtual appliance, and includes a suite of subscription services, as well as support and maintenance services. The company’s products include firewall appliances; Panorama, a centralized security management solution for the global control of appliances deployed on an end-customer’s network as a virtual appliance or a physical appliance; and Virtual System Upgrades, which are available as extensions to the virtual system capacity that ships with the appliance. Its subscription services include threat detection and prevention, URL filtering, laptop and mobile devices protection, and malware and threats protection. The company also offers professional services, which include on-location planning, designing, and deployment of security solutions; application traffic management, solution design and planning, configuration, and firewall migration; and education services. Its platform enables enterprises, service providers, and government entities to identify, control, and safely enable applications running on their networks, as well as protect against cyber threats in real time. The company serves the enterprise network security market, which consists of firewall, unified threat management, Web gateway, intrusion detection and prevention, and virtual private network technologies. The company primarily sells its products and services through its channel partners, as well as directly to end-customers operating in various industries, including education, energy, financial services, healthcare, Internet and media, manufacturing, public sector, and telecommunications. Palo Alto Networks, Inc. was founded in 2005 and is headquartered in Santa Clara, California.

Get a Free Technical Analysis on Palo Alto Networks, Inc. (NYSE:PANW): http://pennystocksites.com/market-scan/?symbol=panw

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs. Its clinical stage oncology candidates comprise Archexin, an inhibitor of the protein kinase Akt-1, which has completed a Phase IIa clinical trial for the treatment of pancreatic cancer, as well as is focusing on initiating Phase IIa clinical trials for chemo-resistant solid tumors and hematological malignancies; RX-3117, which has completed an exploratory Phase I clinical study in humans with therapeutic potential in a range of cancers, including colon, lung, and pancreatic cancer; and RX-5902, a small molecule that inhibits the phosphorylation of p68 RNA helicase and focuses on initiating Phase I clinical trials. The company’s pre-clinical pipeline consist of RX-0201-Nano, a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, a nanoliposomal anticancer HIF-1 alpha inhibitor; and RX-21101, nano-polymer anticancer. It has various collaborative research and development relationships with universities, research institutions, and other organizations, including Teva Pharmaceutical Industries; Korea Research Institute of Chemical Technology; The University of Maryland Baltimore; Revaax Pharmaceuticals LLC; and Rexgene Biotech Co., Ltd. The company is based in Rockville, Maryland.

Get a Free Technical Analysis on Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN): http://pennystocksites.com/market-scan/?symbol=rnn

Photon Tech Intl Inc. (OTCMKTS:PHTO), Photon Technology International, Inc. (PTI) designs, manufactures and markets proprietary electro-optical instruments. Our products are used in leading laboratories around the world for medical research, health care, industrial process, quality control, environmental science and other applications. PTI distinguishes itself in the photonics industry by devoting its resources exclusively to the technology of fluorescence instrumentation and by providing exceptional product support. With offices worldwide, PTI has been recognized for outstanding technological achievement, business growth and corporate environment.

Get a Free Technical Analysis on Photon Tech Intl Inc. (OTCMKTS:PHTO): http://pennystocksites.com/market-scan/?symbol=phto

Alternative Energy Partners, Inc. (OTCBB:AEGY), Alternative Energy Partners, Inc., a development stage company, is engaged in providing support services for medical marijuana collectives based in California. It focuses on developing PharmaJanes, a Web and phone application that allows individuals to place orders for medical marijuana through a Website and smart phone application. The company was founded in 2008 and is based in Boca Raton, Florida.

Get a Free Technical Analysis on Alternative Energy Partners, Inc. (OTCBB:AEGY): http://pennystocksites.com/market-scan/?symbol=aegy

Disclosure
We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://pennystocksites.com/disclaimer/ for complete risks and disclosures.

Contact:
news@pennystocksites.com
http://pennystocksites.com/
http://pennystocksites.com/disclaimer/